Page last updated: 2024-08-25

sultosilic acid and Hyperlipidemia, Familial Combined

sultosilic acid has been researched along with Hyperlipidemia, Familial Combined in 1 studies

*Hyperlipidemia, Familial Combined: A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franco, M; Masana, L; Oliván, JJ; Pérez-Jiménez, F; Pintó, X; Plana, N; Ros, E; Sust, M; Videla, S; Villoria, J1

Trials

1 trial(s) available for sultosilic acid and Hyperlipidemia, Familial Combined

ArticleYear
Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.
    European journal of pharmacology, 2004, Aug-02, Volume: 496, Issue:1-3

    Topics: Adolescent; Adult; Aged; Benzenesulfonates; Cholesterol, LDL; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Pilot Projects; Pravastatin; Statistics, Nonparametric

2004